Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-05-23
2006-05-23
Spector, Lorraine (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C530S350000, C530S413000
Reexamination Certificate
active
07049410
ABSTRACT:
This invention relates to ERRP (EGF-Receptor Related Protein) specific antibodies that could be used 1) to study the functional properties of ERRP and; 2) as a diagnostic and prognostic tool for malignancies. Preferably, the antibody reacts with a segment of ERRP containing 15 amino acids (SEQ ID NO: 4) that possesses the most antigenic property.
REFERENCES:
patent: 5218090 (1993-06-01), Connors
patent: 5550214 (1996-08-01), Eberlein et al.
patent: 5578482 (1996-11-01), Lippman et al.
patent: 5635399 (1997-06-01), Kriegler et al.
patent: 5641484 (1997-06-01), Hung et al.
patent: 5643567 (1997-07-01), Hung et al.
patent: 5650415 (1997-07-01), Tang et al.
patent: 5651964 (1997-07-01), Hung et al.
patent: 5652130 (1997-07-01), Kriegler et al.
patent: 5677171 (1997-10-01), Hudziak et al.
patent: 5693522 (1997-12-01), Chada et al.
patent: 5700822 (1997-12-01), Hirth et al.
patent: 5710173 (1998-01-01), Tang et al.
patent: 5720937 (1998-02-01), Hudziak et al.
patent: 5721277 (1998-02-01), Tang
patent: 5725856 (1998-03-01), Hudziak et al.
patent: 5760066 (1998-06-01), Tang
patent: 5763470 (1998-06-01), Tang et al.
patent: 5770195 (1998-06-01), Hudziak et al.
patent: 5772997 (1998-06-01), Hudziak et al.
patent: 5773459 (1998-06-01), Tang et al.
patent: 5773476 (1998-06-01), Chen et al.
patent: 5789427 (1998-08-01), Chen et al.
patent: 5792783 (1998-08-01), Tang et al.
patent: 5804396 (1998-09-01), Plowman
patent: 5807989 (1998-09-01), Margolis et al.
patent: 5814315 (1998-09-01), Hung et al.
patent: 5814630 (1998-09-01), Barker et al.
patent: 5821246 (1998-10-01), Brown et al.
patent: 5834504 (1998-11-01), Tang et al.
patent: 5837510 (1998-11-01), Goldsmith et al.
patent: 5837523 (1998-11-01), Greene et al.
patent: 5849586 (1998-12-01), Kriegler et al.
patent: 5856089 (1999-01-01), Wang et al.
patent: 5861290 (1999-01-01), Goldsmith et al.
patent: 5863797 (1999-01-01), Kriegler et al.
patent: 5869445 (1999-02-01), Cheever et al.
patent: 5869618 (1999-02-01), Lippman et al.
patent: 5874077 (1999-02-01), Kriegler et al.
patent: 5880141 (1999-03-01), Tang et al.
patent: 5883113 (1999-03-01), Tang et al.
patent: 5883116 (1999-03-01), Tang et al.
patent: 5886020 (1999-03-01), Tang et al.
patent: 5888965 (1999-03-01), Kmiecik et al.
patent: 5889156 (1999-03-01), Kriegler et al.
patent: 5891917 (1999-04-01), Tang et al.
patent: 5914343 (1999-06-01), Tang
patent: 5932574 (1999-08-01), Baker
patent: 5932602 (1999-08-01), Hirth et al.
patent: 5935993 (1999-08-01), Tang et al.
patent: 5942514 (1999-08-01), Barker
patent: 5955464 (1999-09-01), Barker
patent: 5958959 (1999-09-01), Hirth et al.
patent: 5962458 (1999-10-01), Lohmann et al.
patent: 5972639 (1999-10-01), Parandoosh
patent: 5977102 (1999-11-01), Himmelsbach et al.
patent: 5985553 (1999-11-01), King et al.
patent: 5990141 (1999-11-01), Hirth et al.
patent: 5997859 (1999-12-01), Barber et al.
patent: 5998136 (1999-12-01), Kamb
patent: 6015567 (2000-01-01), Hudziak et al.
patent: 6015814 (2000-01-01), Barker
patent: 6040290 (2000-03-01), Lippman et al.
patent: 6051593 (2000-04-01), Tang et al.
patent: 6071512 (2000-06-01), Kriegler et al.
patent: 6071921 (2000-06-01), Lohmann et al.
patent: WO 98/14459 (1998-09-01), None
E. Benjamini et al., “Antigenicity”. Immunology, A Short Course, 2nd Ed.., 1992 (John Wiley & Sons, Inc.), p. 40.
Ullrich et al., Signal Transduction by Receptors with Tyrosine Kinase Activity, Cell, vol. 61, pp. 203-212, 1990.
Reiter et al., A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor, Nucleic Acids Research, 1996, vol. 24, No. 20, pp. 4050-4056.
Margolis et al., EGF Induces Tyrosine Phosphorylation of Phospholipase C-II: A Potential Mechanism for EGF Receptor Signaling, Cell vol. 57, pp. 1101-1107, 1989.
Kypta et al., Association between the PDGF Receptor and Members of the src Family of Tyrosine Kinases, Cell, vol. 62, pp. 481-492, 1990.
Otsu et al., Characterization of Two 85 kd Proteins that Associate with Receptor Tyrosine Kinases, Middle-T/pp60c-srcComplexes, and PI3-Kinase, Cell, vol. 65, pp. 91-104, 1991.
Skolnik et al., Cloning of PI3 Kinase-Associated p85 Utilizing a Novel Method for Expression/Cloning of Target Proteins for Receptor Tyrosine Kinases, Cell, vol. 65, pp. 83-90, 1991.
Escobedo et al., cDNA Cloning of a Novel 85 kd Protein that has SH2Domains and Regulates Binding of PI3-Kinase to the PDGF β-Receptor, Cell, vol. 65, pp. 75-92, 1991.
Kazlauskas et al., Autophosphorylation of the PDGF Receptor in the Kinase Insert Region Regulates Interactions with Cell Proteins, Cell, vol. 58; 1121-1131, 1989.
Kaplan et al., PDGF β-Receptor Stimulates Tyrosine Phosphorylation of GAP and Association of GAP with a Signaling Complex.
Morrison et al., Direct Activation of the Serine/Threonine Kinase Activity of Raf-1 through Tyrosine Phosphorylation by the PDGF β-Receptor, Cell, vol. 58, pp. 649-657, 1989.
Meisenhelder et al., Phospholipase C-y Is a Substrate for the PDGF and EGF Receptor Protein-Tyrosine Kinases In Vivo and In Vitro, Cell, vol. 57, pp. 1109-1122, 1989.
Ruderman et al., Activation of phosphatidylinositol 3-kinase by insulin, Proc. Natl. Acad. Sci., USA, vol. 87, pp. 1411-1415, 1990, Cell Biology.
Kazlaukas et al., Binding of GAP to Activated PDGF Receptors; Science, 1990, pp. 1578-1581.
Coughlin et al., Role ofd Phosphatidylinositol Kinase in PDGF Receptor Signal Transduction, Science, vol. 243, 1989, pp. 1191-1194.
Morrison et al., Signal transduction from membrane to cytoplasm: Growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity; Proc. Natl. Acad. Asc. USA, vol. 89, pp. 8855-8859, 1988 Biochemistry.
Molloy et al., PDGF induction of tyrosine phosphorylation of GTPase activating protein, Letters to Nature, vol. 342, pp. 711-714, 1989.
Varticovski et al., The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase, Letters to Nature, vol. 342, pp. 699-702, 1989.
Fazioli et al., The erbB-2 Mitogenic Signaling Pathway: Tyrosine Phosphorylation of Phospholipase C-y and GTPase-Activating Protein Does Not Correlated with erbB-2 Mitogenic Potency, Molecular and Cellular Biology, 1991, pp./ 2040-2048.
Segatto et al., The Juxtamembrane Regions of the Epiderma1 Growth Factor Receptor and gp185erbB-2Determine the Specificity of Signal Transduction, Molecular and Cellular Biology, 1991, pp. 3191-3202.
Gould et al., Platelet-Derived Growth Facotr Induces Multisite Phosphorylation of pp60c-srcand Increases Its Protein-Tyrosine Kinase Activity, Molecular and Cellular Biology, 1988, pp. 3345-3356.
Wahl et al., Platelet-Derived Growth Factor Induces Rapid and sustained Tyrosine Phosphorylation of Phospholipase C-y in Quiescent BALB/c 3T3 Cells, Molecular and Cellular Biology, 1989, pp. 2934-3943.
Avivi et al., Comparison of EFT receptor sequences as a guide to study the ligand binding site, Oncogene (1991), 6, pp. 673-676.
Rusch et al., The Epidermal Growth Factor Receptor and its Ligands as Therapeutic Targets in Human Tumors, Cytokine & Growth Factor Review, vol. 2, No. 2, pp. 133-141—1996—pp. 133-141.
Cohen, Epidermal Growth Factor, Bioscience Reports, vol. 6, No. 12, 1986—pp. 1017-1028.
Modjtahedi et al., Antitumor Activity of Combinations of Antibodies Directerd Against Different Epitopes on the Extracellular Domain of the Human EGF Receptor, Cell Biophysics, vol. 22, 1993—pp. 129-146.
Buolamwini—Novel anticancer drug discover—pp. 500-509.
Dean et al., Immunotherapy with Antibodies to the EGF Receptor, Int. J. Cancer: Supplement 8, 1994—pp. 103-107.
Scher et al., Changing Pattern of Expressiono of the Epidermal Growth Factor Receptor and Transforming Growth Factor ∂ in the Progression of Prostatic Neoplasms, Clinical Cancer Res., vol. 1, 1995—pp. 545-550.
Kita et al., ErbB Receptor Activation, Cell Morphology Changes, and Apoptosis Induced by Anti-Her2 Monoclonal Antibodies, Biochemical and Biophysical Research Comm., vo
Majumdar Adhip P. N.
Sarkar Fazlul H.
Blank Rome LLP
Jiang Dong
Spector Lorraine
LandOfFree
Antibodies to a novel EGF-receptor related protein (ERRP) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to a novel EGF-receptor related protein (ERRP), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to a novel EGF-receptor related protein (ERRP) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3562912